CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 167 enrolled
Drug / intervention
Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers. +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03093467
NCT03093467N/ACompleted

Effectiveness of an Internet-based Intervention for the Treatment of Depression: Towards the Improvement of the Management of Depression

Instituto Milenio para Investigación en Depresión y Personalidad·interventional·Posted Mar 28, 2017·Updated Apr 8, 2021

In Brief

A clinical study evaluating ASCENSO, Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers., and 1 other intervention for Depression. Completed, enrolled 167 participants across 1 site.

Detailed Summary

Depression is a highly prevalent disorder in Chile, generating important personal and social costs. This study aims to evaluate the effectiveness of the internet-based program ASCENSO as an adjunct intervention for the treatment of depression. ASCENSO provides information to promote patients' self-care, it monitors reported depression symptoms providing automatized feedback and provides the possibility of booking a counseling session via chat or by phone. To evaluate the effectiveness of ASCENSO, an open, evaluator-blind, prospective, parallel-group (one intervention group and one active control group) randomized controlled trial will be implemented in one mental health center in Santiago of Chile. The sample will be composed of adults initiating treatment for depression, and who have internet access. Participants will be randomly assigned to one of the two study arms. Randomization will be stratified by the number of patients´ previous episodes (dichotomized into none, 1 or more), following a permuted block randomization procedure. Patients in the experimental group (n=100) will receive the usual treatment plus access to the ASCENSO program. The control group (n=100) will only receive the usual treatment. At recruitment, months 6 and 9, patients' self-reported depression symptoms and quality of life will be assessed. Additionally, adherence to treatment in terms of patients' attendance to medical controls and psychotherapy sessions will be registered for both research groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesChile

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 28, 2017
Enrollment StartMay 29, 2017
Primary CompletionNov 13, 2019
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.3 years ago

Interventions

ASCENSObehavioral

Internet-based program: an adjunct support and monitoring system for the treatment of depression.

Antidepressants or in combination with anxiolytics, neuroleptics or mood stabilizers.drug

Usual psychiatric treatment which may include drugs: antidepressant monotherapy or antidepressants in combination with anxiolytics, neuroleptics or mood stabilizers as needed, according to the psychiatric evaluation. Monthly controls during 5 months in average.

Psychotherapybehavioral

Usual treatment: brief psychotherapy. One session per week, a total of 9 sessions in average.